Arrhythmia Disorders News

The American Heart Association Scientific Sessions, which will be held live in Philadelphia and can be attended virtually Nov. 10 to 13, will feature eight late-breaking science sessions over 3 days.

iRhythm Technologies announced the U.S. launch of its next-generation cardiac monitoring patch and an enhanced long-term continuous monitoring service.

At 2 years after transcatheter aortic valve replacement with newer-generation devices, approximately 20% of deaths were attributed to advanced HF or sudden cardiac death, researchers reported.

The Care of the Athletic Heart Conference at Heart House in Washington, D.C., catered to clinicians responsible for providing cardiovascular care to athletes, including those at the elite level and exercise enthusiasts.

Persistent atrial fibrillation was associated with worse outcomes and less quality of life benefit after catheter ablation compared with paroxysmal AF, researchers reported.

Pre-participation screening for risk factors for sudden cardiac death with focused cardiac ultrasound was shown to improve diagnosis in athletes while remaining cost-effective, researchers reported.

Anthos Therapeutics announced that the phase 2 AZALEA-TIMI 71 study was stopped early due to an “overwhelming reduction” in bleeding in patients with atrial fibrillation at high risk for stroke taking abelacimab vs. rivaroxaban.

Many U.S. residents live less than 20 km from a cardiologist, but distances in the western U.S. were larger, with some patients traveling more than 100 km to see an HF physician, researchers wrote.

Attune Medical was granted de novo marketing authorization from the FDA for its single-use silicone tube designed to reduce the odds of radiofrequency ablation-related esophageal injury.

Healio | Cardiology Today Editorial Board Member Albert L. Waldo, MD, a pioneer in electrophysiology, died in August, University Hospitals Harrington Heart & Vascular Institute announced.